Top Tech Startups in Earth in 2024

We’re a team of designers and engineers focused on bringing the latest in AI to design. We’re passionate about creating a cutting-edge tool that simplifies workflows and maximizes creative control, making it easier for every designer to bring brilliant ideas to life. If you share our passion and want to help kickstart the next creative revolution, we’d love to hear from you!

Dynamic, next-gen budgeting, forecasting, and reporting solutions

Nabta Health (nabtahealth.com) discovers new ways for women to prevent, identify and manage non-communicable diseases (NCDs). The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. NCDs also leave populations more susceptible to communicable diseases such as COVID-19. Moreover, NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Today, women using drugs that were approved pre-1994, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Standardising and personalising the ways in which women identify and manage NCDs in the context of their own lifestyles and health goals, and through the use of applied machine learning and Artificial Intelligence, will improve clinical outcomes and make cutting-edge healthcare affordable and accessible for all women. Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to obtain a formal diagnosis of PCOS within 90 days versus the global average of 2.5 years.

Spentys is a 3D scanning, 3D modeling and 3D printing platform to produce tailor-made orthopedic immobilization devices. With our expertise in 3D scanning, 3D modeling, and 3D printing, we help orthopedic technicians implement 3D technology in their daily practices so that they can develop more comfortable/ better-fitting orthoses or prostheses for their patients faster, more efficiently and cheaper.